Foghorn Therapeutics (FHTX) Other Non-Current Liabilities (2021 - 2026)

Foghorn Therapeutics' Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $453000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities fell 47.08% year-over-year to $453000.0; the TTM figure through Mar 2026 stood at $453000.0 (down 47.08% YoY), while the FY2025 annual figure was $556000.0, changed N/A from the prior year.
• Other Non-Current Liabilities was $453000.0 for Q1 2026 at Foghorn Therapeutics, down from $556000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $856000.0 in Q1 2025 to a low of $29000.0 in Q4 2022.
• Historically, Other Non-Current Liabilities has averaged $396555.6 across 3 years, with a median of $453000.0 in 2026.
• The sharpest annual moves came in 2022 and 2026: Other Non-Current Liabilities plunged 79.72% in 2022, then sank 47.08% in 2026.
• A 3-year view of Other Non-Current Liabilities shows it stood at $29000.0 in 2022, then jumped by 1817.24% to $556000.0 in 2025, then fell by 18.53% to $453000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $453000.0 (Q1 2026), $556000.0 (Q4 2025), and $656000.0 (Q3 2025), per Business Quant data.